Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacira Pharm Inc (NQ: PCRX )

63.58 +0.04 (+0.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 418,225
Open 64.29
Bid (Size) 58.11 (1)
Ask (Size) 76.90 (1)
Prev. Close 63.54
Today's Range 61.68 - 64.36
52wk Range 45.05 - 82.16
Shares Outstanding 44,454,792
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Pacira BioSciences: Q1 Earnings Insights
Pacira BioSciences (NASDAQ:PCRX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Pacira BioSciences Earnings Conference Call Is Coming Up, Here's What You Need To Know
Pacira BioSciences (NASDAQ:PCRX) will host a conference call at 08:30 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga

Performance

YTD
+3.89%
+3.89%
1 Month
-12.90%
-12.90%
3 Month
-1.79%
-1.79%
6 Month
+11.49%
+11.49%
1 Year
+3.21%
+3.21%

More News

Read More
Krystal Biotech Stock Sees Healthy Relative Strength Rating Upgrade
Via Investor's Business Daily
28 Biggest Movers From Yesterday
Via Benzinga
Expert Ratings For Pacira BioSciences
Via Benzinga
Supernus Pharmaceuticals Stock Sees Relative Strength Rating Jump To 92
Via Investor's Business Daily
Stocks That Hit 52-Week Highs On Thursday
Via Benzinga
Biohaven Pharma Holdings Stock Joins Elite Club Of Stocks With RS Ratings Over 90
Via Investor's Business Daily
Apellis Pharmaceuticals Stock Shows Rising Relative Strength
Via Investor's Business Daily
Acadia Pharmaceuticals Stock Shows Market Leadership With Jump To 91 RS Rating
Via Investor's Business Daily
Biocryst Pharmaceuticals Stock Shows Rising Price Performance With Jump To 92 RS Rating
Via Investor's Business Daily
Horizon Therapeutics Stock Shows Market Leadership; Earns 82 RS Rating
Via Investor's Business Daily
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Via Benzinga
Pacira Pharmaceuticals Stock Scores A Healthy 79 Relative Strength Rating
Via Investor's Business Daily
Bear Market Bets In Biotech
Via Talk Markets
Pacira BioSciences, inc (PCRX) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Via Benzinga
Topics Retirement
Exposures Pension
Earnings Scheduled For November 3, 2021
Via Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Via Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Via Benzinga
Exposures COVID-19
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
Via Talk Markets
Topics Stocks
Exposures US Equities
Pacira Beefs Up Non-Opioid Pain Management Via Flexion Acquisition
Via Benzinga
Why Pacira Biosciences Stock Sank Today
Via The Motley Fool
Exposures Product Safety
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.